ATAI Life Sciences NV
General ticker "ATAI" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $241.3M
ATAI Life Sciences NV does not follow the US Stock Market performance with the rate: -19.9%.
Estimated limits based on current volatility of 4.6%: low 1.14$, high 1.25$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.78$, 1.92$]
- 2024-12-30 to 2025-12-30 estimated range: [0.89$, 2.09$]
Financial Metrics affecting the ATAI estimates:
- Negative: Non-GAAP EPS, $ of -0.68 <= 0.10
- Negative: Operating profit margin, % of -99.75 <= 1.03
- Negative: Operating cash flow per share per price, % of -30.41 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.02 <= 0.14
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: -0.96 < Investing cash flow per share, $ of -0.34
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
Short-term ATAI quotes
Long-term ATAI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $20.38MM | $0.23MM | $0.31MM |
| Operating Expenses | $156.18MM | $145.02MM | $125.78MM |
| Operating Income | $-135.81MM | $-144.79MM | $-125.47MM |
| Non-Operating Income | $-0.80MM | $9.61MM | $86.19MM |
| Interest Expense | $0.00MM | $1.92MM | $2.66MM |
| R&D Expense | $47.96MM | $74.31MM | $62.20MM |
| Income(Loss) | $-136.60MM | $-135.18MM | $-39.29MM |
| Taxes | $-3.99MM | $6.23MM | $0.94MM |
| Other Income(Loss) | $-41.63MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-174.24MM | $-141.41MM | $-40.22MM |
| Stockholders Equity | $376.91MM | $260.74MM | $242.96MM |
| Inventory | $0.00MM | $5.63MM | $0.00MM |
| Assets | $414.17MM | $305.44MM | $293.48MM |
| Operating Cash Flow | $-63.25MM | $-104.47MM | $-84.12MM |
| Capital expenditure | $1.13MM | $1.02MM | $0.59MM |
| Investing Cash Flow | $-81.28MM | $-86.85MM | $-53.30MM |
| Financing Cash Flow | $409.86MM | $20.79MM | $-8.36MM |
| Earnings Per Share* | $-0.83 | $-0.91 | $-0.25 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.